Medically-Tailored Meal Intervention
Nutrition therapy in liver disease is centered around preventing disease progression and managing additional complications. Since everything we eat must pass through the liver, special attention to nutrition and diet can support healthy liver functions. Early dietary changes can reduce the stress placed on the liver and can help speed up the recovery process, and medically-tailored meals support positive health outcomes, improve medication adherence, and help avoid malnutrition and repeat hospitalizations.
Allyson Schiff – Business Development Associate, God’s Love We Deliver
Facilitated on: May 11, 2022 @ 2pm ET
The Impact of Hep C in the United States
A discussion about the impact of Hepatitis C in the United States, with specific insights on its impact on the Hispanic/Latinx community.The webinar provides: information about HepVu and hepatitis C in the U.S.; information about the demographics of hepatitis C in the U.S.; and an overview of HepVu site and how to use it.
Dr. Heather Bradley -Assistant Professor of Epidemiology & Biostatistics at the School of Public Health at Georgia State University and HepVu Project Director
Facilitated on: May 18, 2021
Viral Hepatitis National Strategic Plan
The Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination 2021-2025, released on January 7, 2021, is a new phase in the fight against viral hepatitis in the United States. Building on three prior National Viral Hepatitis Action Plans over the last 10 years, the Viral Hepatitis National Strategic Plan is the first to aim for elimination of viral hepatitis as a public health threat in the United States.
Jessica Fung Deerin, PhD, MPH – Viral Hepatitis Policy Advisor, Office of Infectious Disease and HIV/AIDS Policy (OIDP) Office of the Assistant Secretary for Health U.S. Department of Health
Facilitated on: May 12, 2021
The Impact of Hep C in the United States
HepVu and Latino Commission on AIDS discuss the impact of Hepatitis C in the United States, with specific insights on its impact on the Hispanic/Latinx community.The webinar provides: information about HepVu and hepatitis C in the U.S.; information about the demographics of hepatitis C in the U.S.; and an overview of HepVu site and how to use it
Dr. Heather Bradley, Assistant Professor of Epidemiology & Biostatistics at the School of Public Health at Georgia State University and HepVu Project Director
Facilitated on: May 26, 2020
Keeping It Real: Addressing the viral hepatitis epidemics among the Hispanic/Latinx communities amid a pandemic, a conversation with NASTAD
A space to have a conversation about health inequalities and disparities, and hepatitis among the Latinx/Hispanic Community and what policies are impacting the Latinx community.
Dr. Rita Isabel Lechuga, Senior Manager on the Hepatitis team, NASTAD
Boatemaa Ntiri-Reid, Director of Hepatitis Team, NASTAD
Rosy Galván, Director of Health Equity, NASTAD
Facilitated on: May 15, 2020
Hepatitis Prevention and vaccines
This webinar presents a review of Viral hepatitis in general and among Latinos, ways to prevent it and what vaccines we have for it.
Presenter: Luis Mares, LMSW
Director of Community Mobilization
Latino Commission on AIDS
Facilitated on: May 13, 2020
HepVu and Hepatitis C in America
This webinar presented a deep dive into the Hepatitis C epidemic in the United States. HepVu, an interactive online resource that visualizes standardized state-level estimates of people with past or current Hepatitis C infection across the country, presented national- and state-level maps and resources on viral hepatitis, including how the opioid epidemic and increased injection drug use have impacted the Hepatitis C epidemic.
Presenter: Heather Bradley, Ph.D.
Professor of Epidemiology, Georgia State University
Project Director, HepVu
Viral Hepatitis: The Basics
This webinar reviewed the basic information about viral hepatitis with a focus on Hepatitis C, that everyone should be aware of. This webinar explored the practices that may place people at risk for viral hepatitis transmission and identify preventive measures and harm reduction strategies to reduce their risk. Screening recommendations and key considerations for care and treatment were addressed.
Presenter: Paul Bolter, Community Outreach & Education Manager, American Liver Foundation/Greater New York Division
OMHRC Efforts around Viral hepatitis C among Hispanics/Latinos
Join us in this webinar where the Office of Minority Health Resource Center (OMHRC), a nationwide service of the HHS office of Minority Health, has been invited by the Latino Commission on AIDS to present on OMHRC’s Efforts Around Viral Hepatitis C among Hispanics/Latinos . This webinar will present current data available on hepatitis, OMHRC’s recent projects and a hepatitis curriculum for community health workers in Spanish currently in development.
Presenter: Diana Echenique, M.P.H., CHI, CDEc; Senior Program Analyst, Hispanic/Latino Communities, Office of Minority Health Resource Center
Latinos and Hepatitis C: Where We Are and What We Need to Do
The current urgency in behavioral health care is the opioid crisis in the US. Unfortunately, not enough is being said about the consequent increased rates of hepatitis C (HCV) infections and its disproportionate impact on the Latino and Hispanic population, a traditionally underrepresented community in research and data collecting. Although injection drug use is the most efficient and prevalent form of HCV transmission, other risk groups include Latino MSMs, Hispanic baby boomers, and those living with or at risk for HIV.
This webinar will discuss how the opioid epidemic has inflated rates of hepatitis C infections amongst Latino persons. Content will provide a brief overview of HCV, the need to address inequitable access to screening, diagnosis and linkage to health care, and will further inform on effective strategies to address hepatitis C with the Latino and Hispanic population.
Presenter: Diana Padilla, Program Manager, RCR, CASAC-T NDRI-USA / NeC ATTC
Updated National Viral Hepatitis Action Plan 2017-2020
The National Viral Hepatitis Action Plan 2017-2020 (Action Plan) is a new phase in the fight against viral hepatitis in the United States. The updated plan outlines four major goals, strategies to achieve those goals, and indicators to help track progress between now and 2020.
This webinar will walk participants through the Action Plan, discuss new emerging issues related to the high incidences in Viral Hepatitis and introduce a tool designed to conduct strategic planning efforts for Hepatitis B and/or Hepatitis C (HCV).
Presenter: Lissette Marrero, MSW, Regional Resource Consultant; U.S. Department of Health and Human Service; Office of the Assistant Secretary for Health, Region II
Viral Hepatitis Overview
The Webinar will review important facts about Viral Hepatitis, focusing more specifically on Hepatitis C. We will provide an overview in terms of the “WHY” we are highlighting the topic. We will discuss the consequences this infectious inflammatory process and more than a presentation on epidemiology, signs and symptoms and treatment, the presenter will explain how Viral Hepatitis causes acute and chronic inflammation, leading to morbidity and mortality.
Presenter: Dr. Richard Torres, MD, MPH, FACP, FACGS, AAHIVM Associate Professor of Medicine Yale University School of Medicine Urban Health Plan, Inc., Associate Medical Director for Community and Public Health
Community Voice: Aracelis Quinones speaks about her own experience with Hep C
Araceli Quinones speaks about her experience of having been diagnosed with hepatitis, treatment experiences and cure. Do you or someone you know have hepatitis? This is a first-hand opportunity to ask questions and chat with Aracelis.
Presenter: Aracelis Quiñones, Poder Latino/U=U Coordinator, Vida Positiva Consultant, Advocate, Latino Commission on AIDS